B-Cell Non-Hodgkin Lymphoma (1)

B-cell Non-Hodgkin Lymphoma (1)

Hematopoietic and Lymphoid Cell Neoplasm (1)

Leukemia (1)

Lymphoma (1)

Plasma Cell Myeloma (1)

T-Cell Non-Hodgkin Lymphoma (1)

Active, not recruiting (1)

Recruiting (1)

phase 1/phase 2 (1)

phase 2 (1)

Hoffmann-La Roche (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

ipilimumab (1)

lenalidomide (1)

mosunetuzumab (iv) (1)

mosunetuzumab (sc) (1)

polatuzumab vedotin (1)

rituximab (1)

tocilizumab (1)

drug (2)

biological (1)

Industry (1)

Other (1)

Interventional (2)

B-Cell Non-Hodgkin Lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS